Adverse effects of a single dose of (+)-sotalol in patients with mild stable asthma

British Journal of Clinical Pharmacology

Volumn 46, Issue 1, 1998, Pages 79-82

  Devereux, G ^a   Fishwick, K ^a   Aiken, T C ^a   Bourke, S J ^a   Hendrick, D J ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

( ) sotalol; (+) sotalol; Airway responsiveness; Asthma; Ventilatory function

Indexed keywords

SOTALOL;

ADULT; AGED; ARTICLE; ASTHMA; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AGED; AIRWAY RESISTANCE; ASTHMA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SOTALOL;

EID: 0031831992     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00039.x     Document Type: Article

References (14)

1. Antonaccio MJ, Gomoll AW. Pharmacologic basis for the anti-arrhythmic and haemodynamic effects of sotalol. Am J Cardiol 1990; 72(Suppl): 27-37.
2. Funck-Brentano C, Silberstein DJ, Roden DM. A mechanism of d-(+) sotalol effects on heart rate not related to beta-adrenoreceptor antagonism. Br J Pharmacol 1990; 30: 195-202.
3. Kato R, Ikeda N, Yabek R. Electrophysiologic effects of the levo-and dextro-rotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol 1986; 7: 116-125.
4. Gomoll AW, Bartek MJ. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anaethetised dogs. Eur J Pharmacol 1986; 132: 123-135.
5. Levy JV, Richard V. Inotropic and chronotropic effects of a series of beta-adrenergic blocking drugs: some structure activity relationships. Proc Soc Exp Biol Med 1966; 122: 373-385.
6. Yasuda SU, Barbey JT, Funck-Brentano C. (+)-sotalol reduces heart rate in vivo through a β-adrenergic receptor-independent mechanism. Clin Pharmacol Ther 1993; 53: 436-42.
7. Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981; 36: 575-579.
8. Zaid G, Beall GN. Bronchial response to beta-adrenergic blockade. N Engl J Med 1966; 275: 580-584.
9. Tobias JD, Sauder RA, Hirshman CA. Pulmonary reactivity to methacholine during β-adrenergic blockade: Propranolol versus Esmolol. Anesthesiol 1990; 73: 132-136.
10. Beach JR, Young CL, Stenton SC, et al. Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and method of assessing response. Thorax 1993; 48: 239-243.
11. SPSS for Windows, Release 6. SPSS Inc, Chicago, Illinois.
12. Connolly MJ, Avery AJ, Walters EH, Hendrick DJ. The relationship between bronchial responsiveness to methacholine and bronchial responsiveness to histamine in asthmatic subjects. Pulmonary Pharmacol 1988; 1: 53-58.
13. Poirer IM, Jaillon P, Lecocq B, Lecocq V, Ferry A, Cheymol G. The pharmacokinetics of d-sotalol and dl-sotalol in healthy volunteers. Eur J Clin Pharmacol 1990; 38: 579-582.
14. Kimura M, Unemura K, Ikeda Y, et al. Pharmacokinetics and pharmacodynamics of (±)-sotalol in healthy male volunteers. Br J Clin Pharmacol 1996; 42: 583-588.